PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Embelin can protect mice from thioacetamide-induced acute liver injury.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31545222 ↗2019Reported benefit

Embelin can protect mice from thioacetamide-induced acute liver injury.

MouseChemical/toxinC57BL/6femaleintragastric gavage50 microgram per gram body weightStarted 2 days before thioacetamide administration

Model: Thioacetamide-induced acute liver injury (single injection, 300 microgram per gram body weight)

Embelin pretreatment improved survival and liver function relative to thioacetamide alone, reduced hepatic necrosis and apoptosis, and brought forward inflammatory cell infiltration, fibrogenesis and macrophage activity consistent with earlier healing.

Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.